BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 23757617)

  • 1. Pancreatic neuroendocrine tumor in a child with a tuberous sclerosis complex 2 (TSC2) mutation.
    Bombardieri R; Moavero R; Roberto D; Cerminara C; Curatolo P
    Endocr Pract; 2013; 19(5):e124-8. PubMed ID: 23757617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tuberous sclerosis complex mutations in patients with pancreatic neuroendocrine tumors. Observations on phenotypic and treatment-related associations.
    Navale P; Chatterjee D; Itani M; Trikalinos NA
    Virchows Arch; 2023 Aug; 483(2):167-175. PubMed ID: 37354253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic neuroendocrine tumors in patients with tuberous sclerosis complex.
    Larson AM; Hedgire SS; Deshpande V; Stemmer-Rachamimov AO; Harisinghani MG; Ferrone CR; Shah U; Thiele EA
    Clin Genet; 2012 Dec; 82(6):558-63. PubMed ID: 22035404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroendocrine tumor of the pancreas in a patient with tuberous sclerosis: a case report and review of the literature.
    Díaz Díaz D; Ibarrola C; Goméz Sanz R; Pérez Hurtado B; Salazar Tabares J; Colina Ruizdelgado F
    Int J Surg Pathol; 2012 Aug; 20(4):390-5. PubMed ID: 22169969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expanding the Spectrum of Colonic Manifestations in Tuberous Sclerosis: L-Cell Neuroendocrine Tumor Arising in the Background of Rectal PEComa.
    Kolin DL; Duan K; Ngan B; Gerstle JT; Krzyzanowska MK; Somers GR; Mete O
    Endocr Pathol; 2018 Mar; 29(1):21-26. PubMed ID: 28733877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Well-differentiated pancreatic neuroendocrine carcinoma in tuberous sclerosis--case report and review of the literature.
    Arva NC; Pappas JG; Bhatla T; Raetz EA; Macari M; Ginsburg HB; Hajdu CH
    Am J Surg Pathol; 2012 Jan; 36(1):149-53. PubMed ID: 22173120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic Neuroendocrine Tumor in a Young Child With Tuberous Sclerosis Complex 1.
    Mehta S; Rusyn L; Ginsburg H; Hajdu C; Kohn B
    J Endocr Soc; 2019 Jun; 3(6):1201-1206. PubMed ID: 31187078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberous sclerosis complex-associated nonfunctional pancreatic neuroendocrine tumors: Management and surgical outcomes.
    Evans LM; Geenen KR; O'Shea A; Hedgire SS; Ferrone CR; Thiele EA
    Am J Med Genet A; 2022 Sep; 188(9):2666-2671. PubMed ID: 35612824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localization of tuberous sclerosis 2 mRNA and its protein product tuberin in normal human brain and in cerebral lesions of patients with tuberous sclerosis.
    Kerfoot C; Wienecke R; Menchine M; Emelin J; Maize JC; Welsh CT; Norman MG; DeClue JE; Vinters HV
    Brain Pathol; 1996 Oct; 6(4):367-75. PubMed ID: 8944308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of S664 TSC2 phosphorylation as a marker for extracellular signal-regulated kinase mediated mTOR activation in tuberous sclerosis and human cancer.
    Ma L; Teruya-Feldstein J; Bonner P; Bernardi R; Franz DN; Witte D; Cordon-Cardo C; Pandolfi PP
    Cancer Res; 2007 Aug; 67(15):7106-12. PubMed ID: 17671177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis of multifocal micronodular pneumocyte hyperplasia and lymphangioleiomyomatosis in tuberous sclerosis and association with tuberous sclerosis genes TSC1 and TSC2.
    Maruyama H; Ohbayashi C; Hino O; Tsutsumi M; Konishi Y
    Pathol Int; 2001 Aug; 51(8):585-94. PubMed ID: 11564212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Significance of P504s in distinction between solid pseudopapillary tumor of pancreas and pancreatic neuroendocrine tumors].
    Chen Z; Shi H; Ying L; Zhai X; Fu X; Liu Q; Lou S
    Zhonghua Bing Li Xue Za Zhi; 2015 May; 44(5):320-2. PubMed ID: 26178213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant pancreatic tumour within the spectrum of tuberous sclerosis complex in childhood.
    Verhoef S; van Diemen-Steenvoorde R; Akkersdijk WL; Bax NM; Ariyurek Y; Hermans CJ; van Nieuwenhuizen O; Nikkels PG; Lindhout D; Halley DJ; Lips K; van den Ouweland AM
    Eur J Pediatr; 1999 Apr; 158(4):284-7. PubMed ID: 10206124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regionally specific TSC1 and TSC2 gene expression in tuberous sclerosis complex.
    Li Y; Barkovich MJ; Karch CM; Nillo RM; Fan CC; Broce IJ; Tan CH; Cuneo D; Hess CP; Dillon WP; Glenn OA; Glastonbury CM; Olney N; Yokoyama JS; Bonham LW; Miller B; Kao A; Schmansky N; Fischl B; Andreassen OA; Jernigan T; Dale A; Barkovich AJ; Desikan RS; Sugrue LP
    Sci Rep; 2018 Sep; 8(1):13373. PubMed ID: 30190613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac rhabdomyomas in tuberous sclerosis complex show apoptosis regulation and mTOR pathway abnormalities.
    Kotulska K; Larysz-Brysz M; Grajkowska W; Jóźwiak J; Włodarski P; Sahin M; Lewin-Kowalik J; Domańska-Pakieła D; Jóźwiak S
    Pediatr Dev Pathol; 2009; 12(2):89-95. PubMed ID: 17990907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging features of tuberous sclerosis complex with autosomal-dominant polycystic kidney disease: a contiguous gene syndrome.
    Back SJ; Andronikou S; Kilborn T; Kaplan BS; Darge K
    Pediatr Radiol; 2015 Mar; 45(3):386-95. PubMed ID: 25355409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A shower of second hit events as the cause of multifocal renal cell carcinoma in tuberous sclerosis complex.
    Tyburczy ME; Jozwiak S; Malinowska IA; Chekaluk Y; Pugh TJ; Wu CL; Nussbaum RL; Seepo S; Dzik T; Kotulska K; Kwiatkowski DJ
    Hum Mol Genet; 2015 Apr; 24(7):1836-42. PubMed ID: 25432535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biallelic Mutations in
    Winden KD; Sundberg M; Yang C; Wafa SMA; Dwyer S; Chen PF; Buttermore ED; Sahin M
    J Neurosci; 2019 Nov; 39(47):9294-9305. PubMed ID: 31591157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic Targeting of the Secreted Lysophospholipase D Autotaxin Suppresses Tuberous Sclerosis Complex-Associated Tumorigenesis.
    Feng Y; Mischler WJ; Gurung AC; Kavanagh TR; Androsov G; Sadow PM; Herbert ZT; Priolo C
    Cancer Res; 2020 Jul; 80(13):2751-2763. PubMed ID: 32393662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of combined inhibition of mTOR and ERK/MAPK pathways in treating a tuberous sclerosis complex cell model.
    Mi R; Ma J; Zhang D; Li L; Zhang H
    J Genet Genomics; 2009 Jun; 36(6):355-61. PubMed ID: 19539245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.